PishPosh, Inc. Announces Postponement of its Initial Public Offering PR Newswire LAKEWOOD, N.J., March 9, 2023 LAKEWOOD, N.J., March 9, 2023 /PRNewswire/ -- PishPosh, Inc. (NASDAQ: BABY...
PishPosh, Inc. Announces Pricing of $9.1 Million Initial Public Offering PR Newswire LAKEWOOD, N.J., March 8, 2023 LAKEWOOD, N.J., March 8, 2023 /PRNewswire/ -- PishPosh, Inc. (NASDAQ: BABY...
Second quarter revenue of $125.5 million exceeded expectationsSecond quarter GAAP earnings per share of $0.12Second quarter non-GAAP earnings per share of $0.34 exceeded expectationsNASDAQ...
PLEASANTON, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the...
PLEASANTON, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will release...
PLEASANTON, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present...
GAAP loss per share changed to $0.89 from $0.74No change to non-GAAP earnings per share PLEASANTON, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) (the...
First quarter revenue of $114.8 millionFirst quarter GAAP loss per share of $0.74; non-GAAP earnings per share of $0.09 PLEASANTON, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Natus Medical...
PLEASANTON, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will...
PLEASANTON, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales